BDH Industries Limited

BSE: 524828
BDH Industries Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L24100MH1990PLC059299 Incorporated 05 December 1990 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 524828 Public Limited Company pharma MSME · Small
Data last updated
Market Cap
₹239 Cr
BDH · BSE
Share Price
₹413.00
-2.82% today
Revenue
₹95.95 Cr
FY 2025-26 · +44.3% YoY
EBITDA
₹13.87 Cr
Margin 14.5%
Net Profit
₹10.80 Cr
FY 2025-26 · +16.3% YoY
P/E (TTM)
20.9x
P/B 3.2x
ROE
15.1%
ROCE 20.8%
Debt / Equity
0.02
Interest cover 0.5x

About BDH Industries Limited

Data last updated:

BDH Industries Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 December 1990 and has been in existence for over 36 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24100MH1990PLC059299. Its GSTIN is 27AAACB1720H1Z6 (Maharashtra). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 524828.

The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹5.76 Cr. It was formerly known as Bdh Industries Private Limited. It is led by directors including Jayashree Gopakumar Nair (Managing Director) and Suresh Chandra Kachhara (Managing Director).

Its last annual general meeting (AGM) was held on 08 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Nair Baug Akurli Road Kandivli (East), Mumbai, Maharashtra, India – 400101.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹95.95 Cr, a growth of 44.3% compared to the previous year. For the same year it recorded a net profit of ₹10.8 Cr (net margin 11.3%) and EBITDA of ₹13.87 Cr (EBITDA margin 14.5%). The net worth stands at ₹77.02 Cr (up 12% YoY). Total assets are valued at ₹79.22 Cr (up 13.3% YoY).

The company has about 77 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: BDH Industries. As per MCA filings, the company has open charges of ₹20.8 Cr and satisfied charges of ₹49.89 Cr on record. Court records list 81 cases involving the company, including 34 filed by the company and 47 filed against it; 10 cases are pending. The company has 35 deals on record (35 market trades); the latest was in September 2025. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Martin & Brown Bio-Sciences Private Limited with revenue of ₹88.52 Cr.

BDH Industries Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0068540). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bdhind.com.

Company details

CIN L24100MH1990PLC059299
Registration Number 059299
Incorporation Date 05 December 1990
ROC Mumbai
Listing Status Listed - Listed on BSE (524828)
Company Status Active
Date of Last AGM 08 August 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0068540

CIN history

BDH Industries has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100MH1990PLC059299, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24100MH1990PLC059299Current
L24230MH1990PLC059299Previous
L40300MH1990PLC059299Previous
Key People
Jayashree Gopakumar Nair Managing Director Suresh Chandra Kachhara Managing Director Karthika Nair Director

Recognitions & Rankings of BDH Industries

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-18-0068540

Contact details

BDH Industries Limited's registered office is in Mumbai, Maharashtra. Its website is bdhind.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    bdhind.com
  • Registered Address
    Nair Baug Akurli Road Kandivli (East), Mumbai, Maharashtra, India – 400101
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of BDH Industries Limited, buy the company report.

Comprehensive company report
BDH Industries Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

BDH Industries operates one associated brand: BDH Industries. Each brand links to its own profile.

BrandDescriptionWebsite
BDH Industries
Therapeutic pharmaceutical formulations are manufactured in Mumbai.bdhind.com

Business activity

The main business activities of BDH Industries are manufacturing and electricity, gas, steam and air condition supply. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and electric power generation, transmission and distribution. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
DElectricity, gas, steam and air condition supplyD1Electric power generation, transmission and distribution

To see the full business activity and turnover split of BDH Industries Limited, buy the company report.

Financials of BDH Industries Limited

FY 2025-26 filings available

BDH Industries Limited reported revenue of ₹95.95 Cr (up 44.3% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹95.95 Cr
+44.3% YoY
EBITDA
₹13.87 Cr
+19.4% YoY
Profit After Tax
₹10.80 Cr
+16.3% YoY
Net Worth
₹77.02 Cr
+12.0% YoY
Total Assets
₹79.22 Cr
+13.3% YoY
Total Debt
₹2.02 Cr
+106.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue95.9566.5185.8374.4669.3957.4559.48
Revenue growth+44.3%-22.5%+15.3%+7.3%+20.8%-3.4%-
EBITDA13.8711.6212.4410.949.078.518.98
EBITDA margin+14.5%+17.5%+14.5%+14.7%+13.1%+14.8%+15.1%
Profit before tax15.1812.4813.2711.059.548.748.13
Net profit10.809.299.898.196.876.355.96
Net profit margin+11.3%+14.0%+11.5%+11.0%+9.9%+11.1%+10.0%
EPS (₹)18.7816.1117.1414.2512.5510.7110.01
Balance sheet
Total assets79.2269.9471.0160.2351.5352.4248.16
Net worth77.0268.7662.1654.7048.5943.0738.24
Total debt2.020.988.694.852.258.519.22
Cash & bank29.3531.1625.1425.9618.8222.6222.99
Net working capital61.8550.8150.6040.7131.7732.1027.11
Cash flow
Cash from operations(2.41)14.77(1.87)6.293.020.7811.35
Cash from investing2.221.62(0.31)0.491.381.290.74
Cash from financing(1.61)(10.37)1.360.37(8.21)(2.44)(6.37)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue22.3829.0329.3418.9618.6217.8216.2016.23
Revenue growth (YoY)+20.2%+62.9%+81.1%+16.8%+14.5%---
Other income0.450.610.530.550.550.570.460.43
Total expenses18.9124.8325.1115.6316.5114.7612.6713.18
EBITDA3.474.204.233.332.113.063.533.05
EBITDA margin+15.5%+14.5%+14.4%+17.6%+11.3%+17.2%+21.8%+18.8%
Depreciation0.210.220.220.220.220.230.230.23
Interest0.010.010.010.030.010.010.010.04
Profit before tax3.704.584.533.632.433.393.753.21
Tax0.971.711.041.010.610.910.940.81

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 10 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue22.3829.0329.3418.9618.6217.8216.2016.23
Revenue growth (YoY)+20.2%+62.9%+81.1%+16.8%+14.5%---
Other income0.450.610.530.550.550.570.460.43
Total expenses18.9124.8325.1115.6316.5114.7612.6713.18
EBITDA3.474.204.233.332.113.063.533.05
EBITDA margin+15.5%+14.5%+14.4%+17.6%+11.3%+17.2%+21.8%+18.8%
Depreciation0.210.220.220.220.220.230.230.23
Interest0.010.010.010.030.010.010.010.04
Profit before tax3.704.584.533.632.433.393.753.21
Tax0.971.711.041.010.610.910.940.81
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue95.9566.5185.8374.4669.3957.4559.48
Revenue growth+44.3%-22.5%+15.3%+7.3%+20.8%-3.4%-
Other income2.241.841.580.841.331.300.80
Total expenses82.0854.8973.3963.5260.3248.9450.50
Employee cost7.557.447.436.966.626.267.50
EBITDA13.8711.6212.4410.949.078.518.98
EBITDA margin+14.5%+17.5%+14.5%+14.7%+13.1%+14.8%+15.1%
Depreciation0.870.910.570.570.630.790.96
Interest0.060.070.180.160.230.280.69
Profit before tax15.1812.4813.2711.059.548.748.13
Tax4.383.193.382.862.332.392.17
Net profit10.809.299.898.196.876.355.96
Net profit margin+11.3%+14.0%+11.5%+11.0%+9.9%+11.1%+10.0%
EPS (₹)18.7816.1117.1414.2512.5510.7110.01
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital5.765.765.765.765.765.945.94
Reserves & surplus71.2663.0056.4048.9442.8337.1332.30
Shareholders' funds (net worth)77.0268.7662.1654.7048.5943.0738.24
Secured loans2.020.988.694.852.258.519.22
Unsecured loans0.000.000.000.000.000.000.00
Total debt2.020.988.694.852.258.519.22
Total liabilities79.2269.9471.0160.2351.5352.4248.16
Assets
Gross block38.0738.0437.8335.9435.9335.9835.97
Net block18.8219.6620.3519.0419.6120.3021.10
Capital work in progress0.000.000.000.000.000.000.00
Investments0.350.350.350.350.000.000.00
Inventories5.377.395.007.166.715.435.01
Sundry debtors31.6114.1828.3616.6414.5215.1811.02
Cash & bank balances29.3531.1625.1425.9618.8222.6222.99
Loans & advances13.4614.0214.0710.719.057.314.94
Total current assets79.7966.7572.5760.4749.1050.5443.96
Total current liabilities17.9415.9421.9719.7617.3318.4416.85
Net working capital61.8550.8150.6040.7131.7732.1027.11
Total assets79.2269.9471.0160.2351.5352.4248.16
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash31.1625.1425.9618.8222.6222.9917.27
Net cash from operating activities(2.41)14.77(1.87)6.293.020.7811.35
Net cash from investing activities2.221.62(0.31)0.491.381.290.74
Net cash from financing activities(1.61)(10.37)1.360.37(8.21)(2.44)(6.37)
Net change in cash(1.81)6.02(0.82)7.15(3.81)(0.37)5.72
Closing cash29.3531.1625.1425.9618.8222.6222.99
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+44.3%-22.5%+15.3%+7.3%+20.8%-3.4%-
EBITDA growth+19.4%-6.6%+13.7%+20.6%+6.6%-5.2%-
PBT growth+21.6%-6.0%+20.1%+15.8%+9.2%+7.5%+24.3%
Net income growth+16.3%-6.1%+20.8%+19.2%+8.2%+6.5%-
Revenue CAGR (3Y)+8.8%-1.4%+14.3%+7.8%+10.3%+11.9%+10.9%
EBITDA CAGR (3Y)+8.2%+8.6%+13.5%+6.8%+9.0%+16.6%+23.4%
Profitability & leverage
Net income margin+11.3%+14.0%+11.5%+11.0%+10.4%+11.1%+10.0%
Return on capital employed+20.8%+18.1%+20.9%+20.6%+19.3%+18.5%+18.9%
Return on net worth+15.1%+14.5%+17.3%+16.3%+16.2%+16.2%+17.0%
Debt / equity0.020.080.120.070.120.230.32
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover0.460.651.521.542.733.638.60
Efficiency & per share
Fixed asset turnover2.611.822.412.152.001.661.72
Inventory turnover15.0410.7414.1210.7411.4311.019.35
Debtors turnover4.193.133.814.784.674.395.04
EPS (₹)18.7816.1117.1414.2512.5510.7110.01
Dividend per share (₹)5.004.504.504.003.603.002.50
Book value per share (₹)131.47117.14105.6792.7182.0770.2462.09

To see the full year-wise statements and ratios of BDH Industries Limited, buy the company report.

Board of directors of BDH Industries Limited

BDH Industries has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jayashree Gopakumar Nair
Also directs: BDH Healthcare Private Limited
Managing Director01 Apr 200917 Years 7 MonthsCurrent
Karthika NairDirector27 Oct 199927 Years 0 MonthsCurrent
Suresh Chandra KachharaManaging Director01 Apr 200917 Years 7 MonthsCurrent
Prabhakar Ramchandra Dalal
Also directs: Carysil Limited, Poonawalla Fincorp Limited
Director01 Apr 20242 Years 7 MonthsCurrent
Mitul Manubhai PatelDirector01 Apr 20242 Years 7 MonthsCurrent
Suresh Chandra KookadaDirector01 Apr 20242 Years 7 MonthsCurrent
View all directors

Peer comparison

BDH Industries Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
BDH Industries Limitedthis company₹95.95 Cr (FY 2026)₹10.8 Cr11.3%44.3%77Mumbai, Maharashtra, India
Martin & Brown Bio-Sciences Private Limited₹88.52 Cr (FY 2025)75.0%Nalagarh, Himachal Pradesh, India
Ravian Life Science Private Limited₹88.41 Cr (FY 2025)2.0%Haridwar, Uttarakhand, India
SRS Pharmaceuticals Private Limited₹88.26 Cr (FY 2025)-10.0%Mumbai, Maharashtra, India
Appasamy Ocular Devices Private Limited₹87.93 Cr (FY 2022)60.0%Chennai, Tamil Nadu, India
Vidacare Medica Private Limited₹87.17 Cr (FY 2025)-13.0%Mumbai, Maharashtra, India
Health Biotech Limited₹86.89 Cr (FY 2025)-22.0%Chandigarh, India
Cyano Pharma Private Limited₹85.89 Cr (FY 2024)38.0%Mumbai, Maharashtra, India
Zenara Pharma Private Limited₹85.73 Cr (FY 2025)3.0%Hyderabad, Telangana, India

To see the full peer comparison of BDH Industries Limited, buy the company report.

Auditor

BDH Industries Limited is audited by CLB & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
CLB & ASSOCIATESFY 2023124305W

Shareholding

Shareholding for the quarter ended Mar 2026: promoters hold 49.70%, foreign institutional investors hold 0.30%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 50.00%.

Promoters: 49.70%FII (Foreign Institutional): 0.30%Retail & Others: 50.00%
Mar 2026
QUARTER
49.70% Promoters
0.30% FII (Foreign Institutional)
50.00% Retail & Others
Promoter holding - history
Now 49.70% · Mar 2026High 49.70% · Jun 2025Low 49.70% · Jun 2025
48%48.8%49.5%50.3%51%Jun 2025Sep 2025Dec 2025Mar 2026Jun 2025: 49.70%Sep 2025: 49.70%Dec 2025: 49.70%Mar 2026: 49.70%49.70%49.70%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025
Promoters49.70%49.70%49.70%49.70%
Public50.30%50.30%50.30%50.30%

Charges & borrowings

Open charges
₹20.8 Cr
Satisfied charges
₹49.89 Cr
Breakdown by lending institutions
Central Bank of India Limited₹18.00 Cr
Central Bank of India₹2.80 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Jun 200610010001Central Bank of India Limited₹18 CrOpen
27 Dec 198490164719Central Bank of India₹1.4 CrOpen
27 Dec 198490167165Central Bank of India₹1.4 CrOpen
26 Feb 201010206984Central Bank of India₹1.8 CrSatisfied
26 May 200610008670Central Bank of India₹2.5 CrSatisfied

To see the full charge records of BDH Industries Limited, buy the company report.

Total charge records: 16 View all charges

Deals & funding

BDH Industries Limited has 35 deals on record (35 market trades); the latest was in September 2025.

Total deals
35
Market trades
35

Deals on record (5 of 35)

WhenDealAmountParties
Sep 2025Market trade₹1.83 CrBuyer: F3 Advisors Private Limited
Seller: F3 Advisors Private Limited
Dec 2023Market trade₹1.44 CrBuyer: Vramath Financial Services Private Limted
Seller: Vramath Investment Consultancy Private Limited
Jul 2023Market trade₹1.32 CrBuyer: Vramath Investment Consultancy Private Limited
Feb 2013Market trade₹11.2 LakhBuyer: an individual
Seller: RS Niwas Private Limited
Aug 2007Market trade₹16.5 LakhBuyer: Shree Naman Securities & Finance Private Limited

To see the full deal history of BDH Industries Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

BDH Industries Limited was last rated by Crisil on 05 Mar 2020.

Rating agencyRated onRating
Crisil05 Mar 2020

To see the full credit ratings and regulatory alerts of BDH Industries Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for BDH Industries Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

BDH Industries Limited has a workforce of 77 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
77
Active EPFO establishments
1
Employee growth
-9.4%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2777
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of BDH Industries Limited, buy the company report.

GST

BDH Industries has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAACB1720H1Z6MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of BDH Industries Limited, buy the company report.

Recent activity

BDH Industries Limited has 18 board changes on record since 1999: 12 appointments and 6 cessations. The latest: Mitul Manubhai Patel was appointed as Director on 01 Apr 2024.

Filing
Bdh Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
AGM
Bdh Industries Limited last Annual general meeting of members was held on 08 Aug 2025 as per latest MCA records.
Appointed
Mitul Manubhai Patel was appointed as Director.
Appointed
Prabhakar Ramchandra Dalal was appointed as Director.
Appointed
Suresh Chandra Kookada was appointed as Director.
Ceased
Bhagirath Singh ceased to be Director.
Ceased
Dinesh Krishanan Variar ceased to be Director.
Ceased
Kairav Anil Trivedi ceased to be Director.
Charges
A charge registered on 12 Dec 2001 via Charge ID 90164192 with Central Bank Of India was fully satisfied on 09 Dec 2020.
Charges
A charge registered on 21 Jul 1999 via Charge ID 90163894 with Central Bank Of India was fully satisfied on 09 Dec 2020.
Charges
A charge registered on 05 Mar 1997 via Charge ID 90160654 with Central Bank Of India was fully satisfied on 09 Dec 2020.
Charges
A charge registered on 08 Apr 1995 via Charge ID 90160653 with Central Bank Of India was fully satisfied on 09 Dec 2020.

47 earlier events are in the company report.

News

Frequently asked questions

BDH Industries is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 December 1990 (36+ years old) and is registered under CIN L24100MH1990PLC059299. Listed on BSE: 524828.

BDH Industries reported revenue of ₹95.95 Cr for FY 2025-26 (up 44.3% YoY) based on standalone financials.

BDH Industries has 6 current directors:

The latest financial statements of BDH Industries on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 08 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of BDH Industries is 27AAACB1720H1Z6, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of BDH Industries is L24100MH1990PLC059299. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. BDH Industries is a listed company as per MCA records. Its shares are listed on BSE (code: 524828).

BDH Industries has 81 court cases on record: 34 filed by the company and 47 filed against it. 10 are pending. Most are in the high courts.

BDH Industries was incorporated on 05 December 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.

BDH Industries has 35 deals on record (35 market trades); the latest was in September 2025.

The peers of BDH Industries by revenue are Martin & Brown Bio-Sciences Private Limited, Ravian Life Science Private Limited, SRS Pharmaceuticals Private Limited, Appasamy Ocular Devices Private Limited, Vidacare Medica Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).